Stewart Schneller and his team of researchers at Auburn University's Chemistry and Biochemistry Department have spent years working to develop new drugs to treat viruses, particularly those that have the ability to turn off the body's immune system, like Ebola. The team has developed a promising new compound designed to combat that process.
"Ebola breaks down the immune system and that causes its dramatic effects. We're trying to block the process by which Ebola turns off the immune response," Schneller explained.
Copyright 2016 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.